Full Editor
Likes Subject
Short Interest for BLTE--Up 30% conix 09/18/22 12:26 PM
BLTE News conix 08/23/22 12:13 PM
'Novel Approach For Retinal Disease Needs' Stock Belite conix 08/02/22 11:15 AM
Belite Bio stock soars 65% in wake of conix 05/04/22 5:58 PM
Great news conix 05/04/22 5:54 PM
Likes Subject

conix
09/18/22 12:26 PM
conix
08/23/22 12:13 PM
conix
05/04/22 5:58 PM
conix
05/04/22 5:54 PM

Belite Bio Inc (BLTE)

Followers
0
Posters
1
Posts (Today)
0
Posts (Total)
5
Created
05/04/22
Type
Free
Moderators


Belite Bio (NASDAQ:BLTE) is a San Diego based clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration, such as atrophic age-related macular degeneration (commonly known as dry AMD) and autosomal recessive Stargardt disease, and metabolic diseases.
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Most Liked Posts
(Last 30 Days)
New Post